BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11310281)

  • 1. [The P300 component of evoked potentials in the evaluation of schizophrenia: new evidence and future visions].
    Martín-Loeches M; Muñoz F; Hinojosa JA; Molina V; Pozo MA
    Rev Neurol; 2001 Feb 1-15; 32(3):250-8. PubMed ID: 11310281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased NoGo-anteriorisation in first-episode schizophrenia patients during Continuous Performance Test.
    Kleinlogel H; Strik W; Begré S
    Clin Neurophysiol; 2007 Dec; 118(12):2683-91. PubMed ID: 17910935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P300 and genetic risk for schizophrenia.
    Winterer G; Egan MF; Raedler T; Sanchez C; Jones DW; Coppola R; Weinberger DR
    Arch Gen Psychiatry; 2003 Nov; 60(11):1158-67. PubMed ID: 14609891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
    Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
    Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder.
    Galletly CA; McFarlane AC; Clark R
    Psychiatry Res; 2008 May; 159(1-2):196-206. PubMed ID: 18423610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of auditory and visual attention in schizophrenia.
    Wood SM; Potts GF; Martin LE; Kothmann D; Hall JF; Ulanday JB
    Psychiatry Res; 2007 Nov; 156(2):105-16. PubMed ID: 17889512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrophysiology and schizophrenic vulnerability: the P300 component as endophenotype candidate?].
    Cermolacce M; Micoulaud JA; Naudin J; Vion-Dury J
    Encephale; 2011 Oct; 37(5):353-60. PubMed ID: 22032278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive dysfunction and electroencephalogram in schizophrenia].
    Matsuoka H; Nakamura M
    Seishin Shinkeigaku Zasshi; 2005; 107(4):307-22. PubMed ID: 15920943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between exploratory eye movement, P300, and reaction time in schizophrenia.
    Takahashi S; Tanabe E; Sakai T; Matsuura M; Matsushima E; Obayashi S; Kojima T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):396-403. PubMed ID: 18778436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies.
    Bestelmeyer PE; Phillips LH; Crombie C; Benson P; St Clair D
    Psychiatry Res; 2009 Oct; 169(3):212-9. PubMed ID: 19748132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic liability to schizophrenia measured by p300 in concordant and discordant monozygotic twins.
    Sharma A; Sauer H; Smit DJ; Bender S; Weisbrod M
    Psychopathology; 2011; 44(6):398-406. PubMed ID: 21968749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [P 300 slow potential. Clinical interest in 3 mental diseases and neurobiology: a review].
    Charles G; Hansenne M
    Encephale; 1992; 18(3):225-36. PubMed ID: 1299592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of perospirone on auditory P300 in schizophrenia: a preliminary study.
    Araki T; Kasai K; Rogers MA; Kato N; Iwanami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1083-90. PubMed ID: 16723179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurophysiological study and use of P300 evoked potentials for investigation in the diagnosis and of follow-up of patients with Alzheimer s disease].
    Fernández- Lastra A; Morales-Rodríguez M; Penzol-Díaz J
    Rev Neurol; 2001 Mar 16-31; 32(6):525-8. PubMed ID: 11353989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings.
    de Wilde OM; Bour LJ; Dingemans PM; Koelman JH; Boerée T; Linszen DH
    Clin Neurophysiol; 2008 Dec; 119(12):2721-6. PubMed ID: 18986832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [P300 and neuropsychological tests in schizophrenia and bipolar patients].
    Vilela C; Vallet M; Salazar J; Tabares R; Selva G; Valanza V; Leal C
    Rev Neurol; 1999 Mar 16-31; 28(6):608-12. PubMed ID: 10714347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Event-related potentials to auditory and visual selective attention in schizophrenia.
    Wood SM; Potts GF; Hall JF; Ulanday JB; Netsiri C
    Int J Psychophysiol; 2006 Apr; 60(1):67-75. PubMed ID: 16009438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Event-related potentials in adolescents with schizophrenia and their siblings: a comparison with attention-deficit/hyperactivity disorder.
    Groom MJ; Bates AT; Jackson GM; Calton TG; Liddle PF; Hollis C
    Biol Psychiatry; 2008 Apr; 63(8):784-92. PubMed ID: 17977520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.